When he enrolled in UConn’s biomedical engineering graduate program in 2005, Eric Sirois wasn’t thinking about a career in business. But an entrepreneurship class that helped him better understand how to commercialize the heart valve implant he’d been developing changed that.
These days, Sirois, CEO of Dura Biotech, a startup participating in UConn’s Technology Incubation Program, is not only prepping his product for animal trials, but attracting funders too.
This past summer the company, founded in 2012, secured two, $400,000 investments — one from the Connecticut Bioscience Innovation Fund, a state-led effort to bring bioscience breakthroughs to market; the other a federal Small Business Innovation Research (SBIR) grant to continue development of its aortic valve implant.
For more on this story, please visit the Hartford Business Journal article.